Amarin Board of Directors Announces Executive Compensation Program for New President and CEO Patrick Holt

Submitted by amarin on Thu, 07/20/2023 - 12:01
– Agreement Underscores Board’s Commitment to Aligning Executive Compensation with  Shareholder Returns – DUBLIN, Ireland and BRIDGEWATER, N.J., July 20, 2023 (GLOBE NEWSWIRE) -- Today the Board of Directors of Amarin Corporation plc (NASDAQ: AMRN) announced details regarding the compensation

Amarin Appoints Patrick Holt as President and Chief Executive Officer

Submitted by amarin on Tue, 07/18/2023 - 20:16
DUBLIN, Ireland and BRIDGEWATER, N.J., July 18, 2023 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ: AMRN) today announced that the Company’s Board of Directors has appointed Patrick Holt as President and Chief Executive Officer and as a member of the Board of Directors, effective immediately.

Amarin Implements Organizational Restructuring to Strengthen the Company While Driving Patient Access to VASCEPA®/VAZKEPA® Globally

Submitted by amarin on Tue, 07/18/2023 - 20:15
-- Focus on Gaining Access for European Patients in Remaining Geographies and Strategic Use of Commercial Resources -- -- Maximizes Cash Flow Opportunity Through Streamlined Model in U.S. -- -- Company Expects Restructuring to Drive Annual Cost Savings of Approximately $40 Million -- -- Announces